NYMC Faculty Publications
Carotid Stenosis: From Diagnosis to Management, Where do We Stand?
Author Type(s)
Faculty
DOI
10.1007/s11883-014-0480-7
Journal Title
Current Atherosclerosis Reports
First Page
480
Last Page
480
Document Type
Article
Publication Date
1-1-2015
Department
Neurology
Keywords
Angioplasty, Balloon, Carotid Artery Diseases, Carotid Stenosis, Endarterectomy, Carotid, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Mass Screening, Risk Assessment, Stents, Stroke
Disciplines
Medicine and Health Sciences
Abstract
Carotid atherosclerosis is implicated in 20-30 % of strokes. However, the annual risk of stroke in patients with asymptomatic carotid stenosis is less than 5 %. Symptomatic carotid stenosis poses a greater risk for recurrent stroke with estimates as high as 15 % per year. This paper aims to raise awareness of populations at risk for carotid stenosis, the role of carotid screening and the sensitivity and specificity of various diagnostic modalities. The results of previous trials that support current guidelines for management of symptomatic and asymptomatic carotid stenosis will also be reviewed.
Recommended Citation
Gokaldas, R., Singh, M., Lal, S., Benenstein, R., & Sahni, R. (2015). Carotid Stenosis: From Diagnosis to Management, Where do We Stand?. Current Atherosclerosis Reports, 17 (2), 480-480. https://doi.org/10.1007/s11883-014-0480-7
